Here, in this study, we show that Med23 deletion leads to impaired HSC self-renewal accompanied with enhanced myeloid differentiation, highlighting the possibility that Med23 may serve similar function in leukemic stem cells (LSCs) and leukemia blast. The gene discussed is MED23; the disease is leukemia.